[Clinical application of PI3K/AKT/mTOR pathway testing in breast cancer] [0.03%]
[PI3K/AKT/mTOR通路检测在乳腺癌临床应用中价值]
M L Sun,Y Q Chen,S Y Cao et al.
M L Sun et al.
[Primary SMARCA4-deficient triple-negative breast cancer: report of a case] [0.03%]
原发SMARCA4阴性三阴性乳腺癌1例报告
B Chang,Y Q Chen,H R Yan et al.
B Chang et al.
[Value of quantitative p53 IHC in predicting TP53 mutation status: a study in lung adenocarcinoma] [0.03%]
[p53免疫组化阳性率预测TP53突变状态的价值研究-以肺腺癌为例]
T L Fan,Q Y Liu,C X Li et al.
T L Fan et al.
[Primary pulmonary epithelioid hemangioendothelioma: a clinicopathological analysis of 40 cases] [0.03%]
原发性肺上皮样血管内皮瘤的临床病理特征分析(40例报告)
T L Wang,X Z Gao,J Han et al.
T L Wang et al.
Objective: To investigate the clinicopathological features of primary pulmonary epithelioid hemangioendothelioma (PEHE). Method: Forty cases of PEHE were diagnosed from October 2010 to June 2024 at the First Affiliated Hospital of Zhengzhou...
[Risk predication for metastasis and grading system in complex adrenal pheochromocytoma and paraganglioma] [0.03%]
[复杂肾上腺嗜铬细胞瘤和副神经节瘤的转移风险预测及分级系统]
L L Wang,S M Yang,X J Wei et al.
L L Wang et al.
Objective: To score pheochromocytoma and paraganglioma (PPGL) by using the composite pheochromocytoma and paraganglioma grading system (COPPS), to analyze the correlations of COPPS, the pheochromocytoma of the adrenal gland scaled score (PA...
[Clinicopathological and molecular genetic features of micronodular thymic neoplasms with lymphoid stroma: a study of seventeen cases] [0.03%]
微结节性淋巴基甲状腺肿瘤的临床病理和分子遗传特征(17例报告)
X Wang,F Zhu,H Wang et al.
X Wang et al.
Objective: To investigate the clinicopathological and molecular genetic features of micronodular thymoma (MNT) and micronodular thymic carcinoma (MNC) with lymphoid stroma. Methods: Seventeen cases of micronodular neoplasms with lymphoid st...
[Prognostic stratification value of MLH1 promoter methylation in endometrioid endometrial carcinomas with a dMMR molecular phenotype] [0.03%]
[错配修复缺陷型子宫内膜样子宫内膜癌中MLH1启动子甲基化的预后分层价值]
H Leng,Z X Song,Y Liu et al.
H Leng et al.
Objective: To investigate the prognostic stratification value of MLH1 promoter methylation in a mismatch repair deficiency (dMMR)-type endometrioid endometrial carcinoma (EEC). Methods: A total of 338 patients with confirmed diagnosis of dM...
[Correlation of STAT6 and HER2-low expression with clinicopathological features and prognosis in triple negative breast cancer] [0.03%]
STAT6和HER2低表达与三阴性乳腺癌临床病理特征及预后的相关性分析
Y J Wang,Y Wang,X Y Ren
Y J Wang
Objective: To investigate the expression of STAT6 and HER2 in triple negative breast cancer (TNBC) and their relationship with clinicopathological features and prognosis. Methods: A total of 189 TNBC samples, including 32 cases with tumor a...